Evolent Health, Inc.

NYSE EVH

Evolent Health, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 13.54%

Evolent Health, Inc. Gross Profit Margin is 13.54% for the Trailing 12 Months (TTM) ending September 30, 2024, a -45.16% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Evolent Health, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 24.68%, a -5.28% change year over year.
Evolent Health, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 26.06%, a -7.24% change year over year.
Evolent Health, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 28.09%, a -9.65% change year over year.
Evolent Health, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 31.10%, a -24.91% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NYSE: EVH

Evolent Health, Inc.

CEO	Mr. Seth Barrie Blackley
IPO Date	June 5, 2015
Location	United States
Headquarters	800 North Glebe Road
Employees	4,700
Sector	Health Care
Industries Hospitals & Clinics Telehealth

Description

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Key trends

Past 5 years